A detailed history of Arvest Investments, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Arvest Investments, Inc. holds 27,008 shares of BMY stock, worth $1.56 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
27,008
Previous 30,652 11.89%
Holding current value
$1.56 Million
Previous $1.27 Billion 9.78%
% of portfolio
0.21%
Previous 0.2%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$39.66 - $51.75 $144,521 - $188,577
-3,644 Reduced 11.89%
27,008 $1.4 Billion
Q2 2024

Aug 08, 2024

SELL
$40.25 - $52.99 $53,371 - $70,264
-1,326 Reduced 4.15%
30,652 $1.27 Billion
Q1 2024

Apr 19, 2024

SELL
$47.98 - $54.4 $259,715 - $294,467
-5,413 Reduced 14.48%
31,978 $1.73 Billion
Q4 2023

Jan 24, 2024

BUY
$48.48 - $57.85 $1.81 Million - $2.16 Million
37,391 New
37,391 $1.92 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Arvest Investments, Inc. Portfolio

Follow Arvest Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arvest Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Arvest Investments, Inc. with notifications on news.